Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | GDTC | BTTC | ||
| Company | Clovis Oncology Inc | Cytomed Therapeutics Limited | Black Titan Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0808 | 1.0400 | 1.3000 | ||
| High | 0.0977 | 1.1000 | 1.3000 | ||
| Low | 0.0766 | 1.0000 | 1.3000 | ||
| Latest | 0.0812 | 1.1000 | 1.3000 | ||
| Change | -0.0048 | +0.0500 | +0.0070 | ||
| % Change | -5.58% | +4.76% | +0.54% | ||
| Volume | 24,516,400 | 8,200 | 4,015 | ||
| 20-Day Average Volume | 9,433,500 | 15,815 | 36,476 | ||
| Previous Close | 0.0860 | 1.0500 | 1.2930 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 1.0600 | 1.4502 | ||
| 20-Day Raw Stochastic | 1.73% | 93.49% | 3.01% | ||
| 20-Day Relative Strength | 23.83 | 51.05 | 31.51 | ||
| Weighted Alpha | -91.19 | -64.59 | N/A | ||
| Today's Opinion | 100% Sell | 48% Sell | N/A | ||
| Previous Opinion | 100% Sell | 72% Sell | N/A | ||
| Last Month's Opinion | 100% Sell | 88% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +3.77% since 03/13/26 | -10.34% since 03/16/26 | ||
| Low | 0.0760 on 12/16/22 | 1.0000 on 03/20/26 | 1.2900 on 03/20/26 | ||
| High | 0.1439 on 12/14/22 | 1.1100 on 03/18/26 | 1.4500 on 03/17/26 | ||
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | +4.76% since 02/20/26 | -16.67% since 02/23/26 | ||
| Low | 0.0760 on 12/16/22 | 0.9564 on 03/03/26 | 1.2900 on 03/20/26 | ||
| High | 0.3772 on 12/01/22 | 1.1100 on 03/18/26 | 1.6220 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -21.99% since 12/19/25 | -36.89% since 12/23/25 | ||
| Low | 0.0760 on 12/16/22 | 0.7282 on 01/27/26 | 1.2900 on 03/20/26 | ||
| High | 1.3100 on 10/04/22 | 1.6000 on 12/31/25 | 3.3200 on 01/20/26 | ||
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -41.02% since 09/19/25 | N/A since 10/02/25 | ||
| Low | 0.0760 on 12/16/22 | 0.7282 on 01/27/26 | 1.2900 on 03/20/26 | ||
| High | 3.2500 on 07/08/22 | 3.6800 on 10/22/25 | 39.0000 on 10/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 12,034 | 11,749 | ||
| Shares Outstanding, K | 144,955 | 10,940 | 9,087 | ||
| Annual Sales | 148,760,000 | 50,000 | 2,683,126 | ||
| Annual Net Income | -264,520,000 | -1,840,000 | -4,710,000 | ||
| Last Quarter Sales | 30,660,000 | N/A | 0 | ||
| Last Quarter Net Income | -56,010,000 | N/A | -690,000 | ||
| 60-Month Beta | 0.24 | -0.36 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | N/A | -0.65 on 08/14/25 | ||
| Latest Earnings Date | 02/22/23 | 04/27/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||